Japanese carmaker Nissan logged a 114.5 billion yen net profit for the three months to June, prompting it to upgrade its annual outlook from 60 billion yen net loss to a 60 billion yen net profit for the year to March 2022.
Nissan suffered a 285.6 billion yen net loss in the same period last year.
The carmaker's quarterly sales surged 71 percent to 2.0 trillion yen, leading it to forecast stronger annual sales.
The firm has faced a series of challenges in recent years, from weak demand during the pandemic to the fallout from the arrest of former boss Carlos Ghosn.
While Nissan could still return to the black in the current fiscal year, analysts say the global chip shortage may cloud its outlook.
Chip supply disruptions were worsened by a fire at a Japanese factory, an extreme cold snap in the US, and a drought in Taiwan.


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
UK Starting Salaries See Strongest Growth in 18 Months as Hiring Sentiment Improves
U.S. Stock Futures Rise as Markets Brace for Jobs and Inflation Data
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Australian Pension Funds Boost Currency Hedging as Aussie Dollar Strengthens
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Australian Household Spending Dips in December as RBA Tightens Policy 



